Pulmopres 20mg Tablet (Tadalafil 20mg)

Description

Pulmopres 20mg Tablet (Tadalafil 20mg) — Complete Clinical and Patient Information Guide

Product Overview

Pulmopres 20mg Tablet (Tadalafil 20mg) contains Tadalafil 20mg as its active pharmaceutical ingredient. It belongs to the phosphodiesterase type 5 (PDE5) inhibitor — long-acting and is clinically indicated for pulmonary arterial hypertension (PAH) and erectile dysfunction — at different dosing regimens. This information guide has been developed in accordance with YMYL (Your Money Your Life) standards, drawing on established pharmacological literature, regulatory prescribing information, and peer-reviewed clinical evidence to provide accurate, balanced, and medically responsible product information for patients and healthcare professionals.

Pulmopres 20mg contains Tadalafil 20mg, distinguished from sildenafil and vardenafil by its exceptionally long half-life of 17.5 hours, providing a clinical window of erectile support lasting up to 36 hours — earning it the colloquial title ‘the weekend pill’. This extended duration allows spontaneous sexual activity without the timing constraints of shorter-acting PDE5 inhibitors, which many men and their partners find significantly more natural and convenient. Pulmopres 20mg is specifically indicated for pulmonary arterial hypertension (PAH), not erectile dysfunction at this dosing regimen. For PAH: 40mg (2x20mg) once daily. For ED: 20mg as needed.

About Pulmopres 20mg and Its Active Ingredient

Tadalafil 20mg is the active pharmaceutical ingredient in Pulmopres 20mg. The drug belongs to the phosphodiesterase type 5 (PDE5) inhibitor — long-acting, a pharmacological class with a well-established clinical evidence base spanning multiple decades of research and real-world clinical use. Understanding the pharmacology, appropriate use, and safety considerations of this medication is essential for achieving optimal therapeutic outcomes while minimising risks — the hallmarks of evidence-based prescribing and responsible patient self-care.

Before initiating therapy with Pulmopres 20mg, patients should disclose their complete medical history, all prescription and over-the-counter medications, herbal supplements, and known allergies to their prescribing physician or pharmacist. Medical supervision is particularly important for conditions classified as YMYL — where the consequences of improper use, incorrect diagnosis, or drug interactions could significantly impact health outcomes.

Mechanism of Action

Tadalafil is a selective PDE5 inhibitor with a pharmacokinetic profile that distinguishes it significantly from sildenafil and vardenafil. Like all PDE5 inhibitors, tadalafil amplifies the NO-cGMP signalling pathway in penile smooth muscle: sexual stimulation triggers NO release, cGMP accumulates, smooth muscle relaxes, and penile arterial inflow increases to produce an erection. Tadalafil’s unique pharmacological characteristics include its exceptionally long half-life of 17.5 hours — producing a clinical window of effectiveness of up to 36 hours — and the fact that food (including high-fat meals) does not significantly affect its absorption, unlike sildenafil. Additionally, tadalafil inhibits PDE11 in addition to PDE5, which may contribute to the back pain and myalgia sometimes reported. At the low 2.5–5mg once-daily dose, tadalafil provides continuous low-level PDE5 inhibition that supports spontaneous erectile response at any time, making it the preferred option for men who desire sexual spontaneity without the need to time a tablet dose before intercourse.

A clear understanding of the mechanism of action helps explain why this medication must be used under specific conditions — why timing relative to meals or sexual activity matters, why certain drug combinations are dangerous, and why the full course of treatment is necessary for maximum benefit. Healthcare providers use mechanistic knowledge to individualise therapy and anticipate interactions.

Clinical Indications

Pulmopres 20mg Tablet (Tadalafil 20mg) is indicated for:

• Primary indication: pulmonary arterial hypertension (PAH) and erectile dysfunction — at different dosing regimens
• Confirmed diagnosis required: Self-diagnosis and self-treatment of conditions managed by prescription medications is strongly discouraged. A qualified physician or specialist should confirm the diagnosis and determine whether this medication is appropriate for the individual patient’s circumstances.
• Treatment goals: The prescribing physician will establish clear therapeutic endpoints — symptom relief, functional improvement, laboratory targets, or lesion clearance — and will monitor response and adjust therapy accordingly.

Dosage and Administration

For PAH: 40mg (two 20mg tablets) once daily. For erectile dysfunction: 20mg as needed, 30 minutes before sexual activity. Do not exceed 20mg in 24 hours for ED use. Consult your specialist for appropriate dosing for your specific indication.

Adherence to the prescribed dosing schedule is critical for achieving therapeutic efficacy and minimising the risk of adverse effects. Patients who are uncertain about their dosing regimen should contact their prescribing physician or pharmacist before making any changes. Never adjust the dose or stop therapy without medical advice.

Who Should Use Pulmopres 20mg

Pulmopres 20mg is appropriate for adult patients who have been diagnosed by a qualified healthcare professional with the conditions listed above and for whom this specific formulation has been prescribed or recommended. Patients with the relevant confirmed diagnosis who have no contraindications to the active ingredient are appropriate candidates.

Contraindications — Who Should Not Use Pulmopres 20mg

Absolute contraindications: Any form of organic nitrate (glyceryl trinitrate/nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite/poppers) — the combination causes unpredictable, potentially life-threatening hypotension through additive cGMP-mediated vasodilation. Soluble guanylate cyclase stimulators (riociguat). Recent myocardial infarction or stroke (within 3–6 months). Unstable angina. Severe cardiac failure (NYHA Class III/IV). Significant hepatic impairment. Hypersensitivity to the active ingredient or excipients. Men for whom sexual activity is medically inadvisable due to cardiovascular risk. Non-arteritic anterior ischaemic optic neuropathy (NAION) in one eye — risk of second eye involvement.

Patients should inform their healthcare provider of all medical conditions and medications before starting Pulmopres 20mg. Self-medication without medical supervision — particularly for prescription medications — carries significant risks including delayed diagnosis of underlying conditions, inappropriate drug use, and preventable adverse effects or drug interactions.

Drug Interactions

Nitrates (all forms): absolute contraindication — potential fatal hypotension. Alpha-blockers (tamsulosin, alfuzosin, doxazosin): additive hypotension — use lowest dose of PDE5 inhibitor and allow ≥4-hour interval if co-prescribed. CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin, erythromycin): significantly increase PDE5 inhibitor plasma levels — reduce PDE5 inhibitor dose (typically 25mg sildenafil maximum). Grapefruit juice: inhibits CYP3A4, increasing sildenafil exposure — avoid. Antihypertensive agents: additive blood pressure reduction — monitor. Alcohol: additive vasodilation and hypotension — advise moderation. Other PDE5 inhibitors: never combine.

Before starting Pulmopres 20mg, perform a complete medication review with a pharmacist or physician. Drug interactions can be clinically significant and potentially dangerous. Many interactions can be managed by dose adjustment, timing modification, or alternative drug selection — but only when identified and evaluated by a qualified professional.

Adverse Effects and Side Effects

Very common (>10%): Headache (most frequent, affecting up to 28% of patients — due to NO-mediated vasodilation in cephalic vessels), facial flushing, and nasal congestion.

Common (1–10%): Dyspepsia, dizziness, and visual disturbances (transient colour tinge or blurred vision — more common with sildenafil due to partial PDE6 inhibition in retinal photoreceptors). Myalgia and back pain more commonly reported with tadalafil (PDE11 activity in skeletal muscle).

Uncommon but important: Hypotension — particularly with concurrent alpha-blocker use, antihypertensive therapy, or alcohol consumption. Priapism — prolonged erection lasting more than 4 hours is a urological emergency requiring immediate medical attention to prevent ischaemic damage to erectile tissue. Non-arteritic anterior ischaemic optic neuropathy (NAION) — rare but serious; risk factors include optic disc anatomy (small cup-to-disc ratio), age, hypertension, diabetes, hyperlipidaemia, and smoking. Sudden sensorineural hearing loss — reported post-marketing, mechanism unclear. Severe skin reactions (Stevens-Johnson syndrome, exfoliative dermatitis) — very rare.

Tadalafil-specific: Back pain and myalgia (limb/muscle aches) — reported in 2–6% of patients at 20mg on-demand, attributed to tadalafil’s activity on PDE11 in skeletal muscle. Usually mild and resolving within 12–24 hours without treatment.

Not all patients experience side effects, and many effects are dose-dependent, transient, or manageable with appropriate supportive measures. Patients should be educated about which side effects require urgent medical attention (severe allergic reactions, priapism for ED medications, signs of intracranial hypertension with retinoids) versus those that are expected and manageable (initial dryness with isotretinoin, retinisation with tretinoin).

Special Population Considerations

Cardiovascular assessment: All men presenting for PDE5 inhibitor therapy should have their cardiovascular fitness for sexual activity assessed. Men in the intermediate cardiac risk category (multiple CV risk factors, stable angina, recent MI >3 months, NYHA Class II heart failure) should be reviewed by a cardiologist before prescribing. Low cardiac risk patients may receive PDE5 inhibitors without further investigation.

Renal impairment: No dose adjustment required for mild-moderate impairment. Sildenafil and vardenafil: start at 25mg in severe renal impairment. Tadalafil: 5mg maximum dose in severe renal impairment (CrCl <30ml/min). Hepatic impairment: Reduce dose by 50% in moderate hepatic impairment (Child-Pugh B). Avoid in severe hepatic impairment (Child-Pugh C).

Elderly (≥65 years): Start at 25mg sildenafil or 50mg vardenafil due to reduced clearance and increased sensitivity. Tadalafil requires no age-based dose adjustment but lower starting doses may be appropriate.

Diabetes mellitus: ED is extremely common in diabetic men, and all three PDE5 inhibitors are effective though response may be somewhat lower than in non-diabetic men — dose titration to maximum tolerated dose may be required.

Storage and Handling

Store Pulmopres 20mg at room temperature (15–25°C), away from direct sunlight, heat sources, and moisture. Keep in original manufacturer’s packaging until required. Store securely out of reach of children and pets. Do not use beyond the printed expiry date. Dispose of unused or expired medication through authorised pharmaceutical take-back services — do not flush or dispose in household waste.

Frequently Asked Questions

Q: How should I store this medication?
A: Store at room temperature (15–25°C), away from direct sunlight, heat, and moisture. Keep in the original packaging out of reach of children. Do not use after the expiry date.

Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember, unless it is nearly time for the next scheduled dose. Do not double-dose. For as-needed medications (PDE5 inhibitors, dapoxetine), the concept of a missed dose does not apply — take when required before sexual activity.

Q: Can I stop this medication abruptly?
A: For most topical acne treatments, stopping does not cause withdrawal, though acne may gradually return. For isotretinoin, complete the prescribed course for maximum benefit. For oral antibiotics, complete the full prescribed course. For PDE5 inhibitors, these are as-needed — no tapering required.

Q: Why is tadalafil called ‘the weekend pill’?
A: Tadalafil’s 17.5-hour half-life produces a clinical window of up to 36 hours — meaning a Friday evening tablet supports erections throughout the weekend without needing to re-dose. This extended window allows more spontaneous sexual activity than shorter-acting sildenafil or vardenafil.

Q: Can I take tadalafil every day?
A: Yes — low-dose daily tadalafil (2.5–5mg) is an approved regimen for men preferring continuous ED management without pre-activity timing. Daily dosing also provides continuous benefit for BPH urinary symptoms, making it particularly valuable for men with both conditions.

Important Medical Disclaimer

This product information page is provided for general educational purposes and is intended to support — not replace — the professional judgement of qualified healthcare providers. All information has been prepared in accordance with YMYL (Your Money Your Life) standards, drawing on regulatory prescribing information, peer-reviewed pharmacological literature, and established clinical guidelines. Drug therapy decisions must be individualised by a licensed physician or pharmacist with full knowledge of the patient’s medical history, comorbidities, and concurrent medications. Self-diagnosis and self-treatment carry significant health risks. If you have questions about this medication or your condition, consult your doctor, dermatologist, or pharmacist.